Don’t miss the latest developments in business and finance.

GSK Pharma's September-quarter profit down 23% to Rs 1.01 billion

The company had posted a net profit of Rs 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing

GlaxoSmithKline, GSK
.
Press Trust of India New Delhi
Last Updated : Oct 22 2018 | 5:46 PM IST

GlaxoSmithKline (GSK)Pharmaceuticals Monday reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended September 30, 2018.

The company had posted a net profit of Rs 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.

Total income of the company stood at Rs 831.13 crore for the reported quarter. It was Rs 845.89 crore in the second quarter of 2017-18.

Shares of GSK Pharma were trading at Rs 1,379.30 per scrip on BSE, down 3.11 per cent from the previous close.

Also Read

First Published: Oct 22 2018 | 2:25 PM IST

Next Story